Kaken Pharmaceutical Co.,Ltd.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Generic Drugs
    • Vaccines
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • Aadi Bioscience
  • ARTham Therapeutics
  • Aadi Subsidiary
  • Kaken Pharmaceutical
See more in Biomedtracker

Latest on Kaken Pharmaceutical Co.,Ltd.

Scrip

Asia Deal Watch: Daiichi Taps Into Wayfinder’s RNA-Encoding Platform

 
• By Jung Won Shin, Lisa Takagi, Joseph Haas, Anju Ghangurde, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Daiichi Sankyo Tries Wayfinder’s

Scrip

Asia Deal Watch: Dr. Reddy’s Gets Regional Rights To Pair Of Bio-Thera Biosimilars

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Dr. Reddy’s Acquires Rights From

Scrip

Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan

 
• By Mandy Jackson

Public biopharma companies usually spend the week before the J.P. Morgan Healthcare Conference announcing new financings, partnerships and sometimes data so that they have compelling milestones to dis

Scrip

Gilead and Leo Pact Adds Fuel To Hot STAT6 Inflammation Space

 
• By Kevin Grogan

Gilead Sciences' acquisition of Leo Pharma’s signal transducer and activator of transcription 6 (STAT6) program is not just a major boost for the Danish group’s finances but also a nod to the growing